Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Change in Accured Expenses (2016 - 2025)

Merit Medical Systems' Change in Accured Expenses history spans 15 years, with the latest figure at -$5.8 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 524.57% year-over-year to -$5.8 million; the TTM value through Dec 2025 reached -$947000.0, down 146.65%, while the annual FY2025 figure was -$947000.0, 146.65% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$5.8 million at Merit Medical Systems, down from $4.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $19.3 million in Q3 2021 and bottomed at -$20.4 million in Q4 2021.
  • The 5-year median for Change in Accured Expenses is $369000.0 (2022), against an average of -$101350.0.
  • The largest annual shift saw Change in Accured Expenses plummeted 1569.59% in 2024 before it soared 2489.02% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$20.4 million in 2021, then soared by 103.85% to $787000.0 in 2022, then crashed by 126.94% to -$212000.0 in 2023, then crashed by 337.74% to -$928000.0 in 2024, then plummeted by 524.57% to -$5.8 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Change in Accured Expenses are -$5.8 million (Q4 2025), $4.2 million (Q3 2025), and $1.3 million (Q2 2025).